Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias

This publication has 10 references indexed in Scilit:

• Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
  Circulation, 1984
• Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome
  American Heart Journal, 1983
• Electrophysiology of oral encainide
  The American Journal of Cardiology, 1982
• Metabolite cumulation during long-term oral encainide administration
  Clinical Pharmacology & Therapeutics, 1982
• Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.
  Circulation, 1981
• Effect of drugs in the wolff-parkinson-white syndrome
  The American Journal of Cardiology, 1980
• Total Suppression of Ventricular Arrhythmias by Encainide
  New England Journal of Medicine, 1980
• Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent
  The American Journal of Cardiology, 1979
• Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drug
  European Journal of Clinical Pharmacology, 1979
• Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias.
  Circulation, 1978